IGF1 and metabolic dysfunction-associated steatotic liver disease: Previous animal studies reported that serum and liver IGF-1 levels were decreased in fatty liver disease caused by insulin resistance, and NAFLD models with low IGF-I levels exhibited impaired muscle strength, function, and lower muscle fiber diameters [136].